Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To compare progression-free survival (PFS) between the two treatment arms based on assessments by an independent review facility (IRF).
Inclusion criteria
- HER2 positive metastatic breast cancer which has progressed after one line of trastuzumab-based therapy in the metastatic setting